Cellular senescence is a stable cell cycle arrest that normal cells undergo in response to a variety of intrinsic and extrinsic stimuli including: progressive telomere shortening, changes in telomeric structure, or other forms of genotoxic as well non-genotoxic stress.
Introduction
The two major pathways which lead to senescent growth arrest, p53/p21 and p16/pRB, are indicated. The p53/p21 pathway can be independently activated by either p14 ARF or the ATM/ATR kinases.
Other cell intrinsic and extrinsic stimuli can also induce senescence independently of telomere length by acting alone or in combination. Senescence-activating signals other than telomere uncapping include DNA damage, oxidative stress, oncogene activity, lack of nutrients, lack of growth factors and improper cell contacts (Figure 1 ). The finding that many diverse stimuli induce cellular senescence initially led to a distinction between "replicative senescence", which occurs following extended proliferation upon reaching 6 the "Hayflick limit" (associated with telomere shortening) and "premature senescence", which occurs before the "Hayflick limit" and is triggered by intrinsic and extrinsic 
Tumour Suppression
The involvement of DNA damage response proteins in inducing senescence suggests a link between cellular senescence and cancer. Cancer cells accumulate genetic alterations which enable them to acquire a limitless proliferative potential, unlike normal cells, which lose the potential to divide at the "Hayflick limit" or upon exposure to stress. Phosphorylation of p53 at key serine residues especially Ser-15, reduces the affinity of the p53-MDM2 interaction, leading to p53 stabilisation and elevated p53 levels. Serine phosphorylation is also required for C-terminal acetylation of lysine residues required to stabilise p53 and enhance sequence-specific DNA binding.
The second mechanism of releasing p53 inhibition is through p14 ARF which increases in 
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Key Cellular Functions of p53
The best-characterised p53 activity is as a master transcriptional regulator, which induces or represses a plethora of genes involved in cell cycle arrest and DNA repair, 
Metabolism, p53 and Tumour Suppression
Altered metabolism is a key change during cancer, allowing pre-cancerous cells to switch from a metabolic reliance on the tricarboxylic acid cycle in the mitochondria to the much more rapid glycolysis followed by lactic acid fermentation in the cytosol, 
Figure 2. Mechanistic target of rapamycin (mTOR).
MTOR is a key protein which governs a cell's choice between division and arrest (72).
Its activity is governed by growth suppressors and growth promoters which can either be intracellular or extracellular. Its activity is important in the context of activated p53 in determining the outcome of the p53 response (74). Cells that sustain mTOR activity undergo a stable senescence growth arrest, whereas cells in which mTOR is inhibited undergo a reversible quiescence arrest (75, 76).
Over the last decade, many studies have demonstrated that p53 counteracts cancerassociated metabolic transformation at various points in the metabolic network, such as in the surveillance of NADPH, which is produced by a range of metabolic enzymes.
NADPH is critical for metabolism, as it is necessary for lipogenesis and facilitates 
